Fineotex Chemicals. IPO Note February 22, Website: SECTOR: CHEMICALS

Transcription

1 IPO Note February 22, 2011 Fineotex Chemicals SECTOR: CHEMICALS AVOID Issue Snapshot Issue Open: 23-Feb-11 Issue Close: 25-Feb-11 Price Band (INR) Issue Size INR 252 mn- INR 303 mn Market Cap INR 673 mn-inr 808 mn Issue Size: 42,11,160 shares QIB: 21,05,580 shares Non-Institutional: 6,31,674 shares Retail: 14,73,906 shares Face Value (INR/share): 10 Book Value as of FY10 (INR) Capital Structure: Pre Issue Equity (INR mn) 70 Post Issue Equity (INR mn) 112 Shareholding Pattern Pre-Issue (%) Post-Issue (%) Promoters & Promoter Group 99.99% 62.49% Others 0.01% 0.01% Public % Total 100% 100% Total Shares Objects of the Issue Sr. No. Particulars INR mn 1 Setting up of new manufacturing facility Sales Office at Mumbai 18 3 Working Capital Requirements 80 4 Public Issue Expenses [.] 5 General Corporate Purposes [.] Total [.] Website: Fineotex Chemical Ltd. (FCL) is in the business of manufacturing specialty chemicals and enzymes consumed by the textile and garment industry, leather, water treatment, construction, paper, paint, adhesives, agrochemical and other industries. FCL s existing plant, with an installed capacity of 5,000 MT/annum, is located at Mahape in Navi Mumbai. The company proposes to set up a new manufacturing facility, at Khopoli in Maharashtra, for the production of specialty chemicals and enzymes with a capacity of 13,125 MT/annum. Investment Rationale Manufactures over 100 Products FCL offers a wide range of specialty chemicals and enzymes used in many industries viz. Textiles & Garments Processing namely the Pre-treatment, Printing, Dyeing and Finishing Process. It also offers specialty performance chemicals to the Leather, Agrochemicals, Construction, Water Treatment, Wood, Sticker and Adhesive Industries etc. Strategic Location of manufacturing Facility FCL procure raw materials from indigenous manufacturers in India like Godrej Industries Limited, Andhra Petroleum Limited, Travancore Titanium Product Limited, etc. who have their warehouses located in close proximity to FCL s manufacturing units. This gives FCL an edge for timely and cost efficient delivery. Investment Concerns Expected delay in the project FCL s inability to acquire the land at Khopoli at the right time, can delay the project or result in an increase in the cost of acquisition; thereby resulting in an increase in the project cost or time overrun thus affecting their operations and profitability. Valuation & Recommendation On the post issue FY10 EPS, the shares are offered at a P/E of 18.6x and 22.3x on lower & upper price band respectively which is higher compared to its peers. Considering the risk involved (as the company is yet to complete the land acquisition process and has client concentration risk) and higher valuation, we recommend AVOID to the issue. Neeraj Toshniwal neeraj.toshniwal@spagroupindia.com

2 Investment Rationale Expansion Plans FCL propose to set up a manufacturing facility for the production of Specialty Chemicals with a capacity of 13,125 MT/annum in and around Khopoli in Maharashtra and to set up a sales office at Mumbai. Setting up this project would be a step towards expansion of current business i.e. manufacturing of Specialty Chemicals for Construction, Textile & Garment, Leather and Water Treatment Industry. This expansion would help FCL to tap the potential of the increasing demand of the specialty chemicals in the above industries. The proposed production unit (in and around Khopoli) will emphasize on having major production quantity under one roof. Also, being geographically located close to Mumbai, JNPT Seaport & Bhiwandi this unit will have proximity and easy access to match supplies & decrease the time for transport of Raw Material & finished goods. The necessary amenities like water; infrastructure being available is an added advantage. Expansion Plans Schedule Particulars (A) Setting up of New Unit Expected start Expected completion Acquisition of land - Apr-11 Execution of Building erection work Jul-11 Sep-11 Installation of P&M Sep-11 Oct-11 Commencement of Prod. & Sales Feb-12 - (B) Setting up of Sales Office Identification & Acquisition of property Apl-11 May-11 Setting up of Furniture & Fixtures Jun-11 Aug-11 Commence Operations Sep-11 - Manufactures over 100 Products of Speciality Chemicals FCL offers a wide range of specialty chemicals and enzymes used in many industries viz. Textiles & Garments Processing namely the Pre-treatment, Printing, Dyeing and Finishing Process. It also offers specialty performance chemicals to the Leather, Agrochemicals, Construction, Water Treatment, Wood, Sticker and Adhesive Industries etc. Company Background Fineotex Chemical Ltd. (FCL) is in the business of manufacturing specialty chemicals and enzymes consumed by the textile and garment industry, leather, water treatment, construction, paper, paint, adhesives, agrochemical and other industries. FCL s existing plant, with an installed capacity of 5,000 MT/annum, is located at Mahape in Navi Mumbai. FCL manufactures over 100 products for various Industries. FCLmajor customers include Pidilite Industries Limited, Croda Chemicals India (P) Limited (formerly ICI India Limited), Rashtriya Chemicals & Fertilizers Limited, The Bombay Dyeing & Mfg. Co. Limited., Raymond Group, and others. Other reputed clients include Grasim Industries Limited, Clariant Chemicals India Limited, JCT Limited etc. Through merchant Exporters it reach in many countries in the world. Key Concerns Expected delay in the project FCL s inability to acquire the land at Khopoli at the right time can delay the project or result in an increase in the cost of acquisition; thereby resulting in an increase in the project cost or time overrun thus affecting their operations and profitability. Competitive environment FCL operate in a very competitive environment as their products are produced by a large number of other manufacturers in India and abroad. Players in this market generally compete with each other on key attributes such as technical competence, quality of products and services, pricing and track record. Customer Concentration risk For FY10, percent of Net Sales contribution from top 5 customers accounted for 56.42% of their total net sales, increasing from 44.79% in FY09 & 31.38% in FY08. 2

3 Industry Background CHEMICAL INDUSTRY Global Chemical Industry The Global Chemical Industry, estimated at US$ 2.4 tn, is one of the fastest growing sectors of the manufacturing industry. According to industry reports the pharmaceutical segment contributes approximately 26% of the total industry output and approximately 35-40% is dominated by the petrochemical segment. Commodity chemical is the largest segment in the chemicals market with an approximate size of $ 750 bn while the Specialty and Fine Chemicals segment accounts for $ 500 bn. Some of the major markets for chemicals are North America, Western Europe, Japan and emerging economies in Asia and Latin America. The US consumes approximately one-fifth of the global chemical consumption whereas Europe is the largest consumer with half the consumption. The US is the largest consumer of commodity chemicals whereas Asia Pacific is the largest consumer of agrochemicals and fertilizers. Indian Chemical Industry The chemical industry includes basic chemicals, petrochemicals, fertilizers, paints and varnishes, gases, soaps, perfumes and toiletries and pharmaceuticals and is one of the most diversified of all industrial sectors covering thousands of commercial products. Its contribution to the GDP of the country is around 3 per cent. Broadly, the share of basic, knowledge, and specialty chemicals is 57%, 18%, and 25%, respectively. The chemical industry is an important constituent of the Indian economy with an estimated turnover at around US$ 35 bn, constituting 1.5% of the global chemical industry estimated at US$ 2400 bn. The total investment in the sector is nearly US$ 60 bn and the employment is about one million. It accounts for 13% 14% of total exports and 8% 9% of total imports of the country. Specialty Chemicals Main specialty chemicals are rubber chemicals, water treatment chemicals, polymer additives, lubricating additives, specialty pigments etc. These chemicals are mainly based on organic chemicals. Globally the contribution of specialty chemicals is upto 25% of the chemical sector i.e. it is approximately worth US$ 453 bn. The average annual growth is expected to be 7.5%. In India, the capacity of specialty chemical is 5272 thousand MTs and production is approx thousand MTs. Valuation & Recommendation On the post issue FY10 EPS, the shares are offered at a P/E of 18.6x and 22.3x on lower & upper price band respectively which is higher compared to its peers. Considering the risk involved (as the company is yet to complete the land acquisition process and has client concentration risk) and higher valuation, we recommend AVOID to the issue. 3

4 Financials Income Statement (INR mn) FY08 FY09 FY10 H1FY11 Balance Sheet (INR mn) FY08 FY09 FY10 H1FY11 Income from Operations Share Capital Inc/(Dec) in Inventory Reserves & Surplus Operating Expenditure Networth Other Income Borrowed Funds EBITDA Def. Tax Liability EBITDAM% 20.0% 19.0% 23.1% 23.7% Current Liabilities & Provisions Depreciation Total Liabilities EBIT Operating Profit Net Block OPM% 20.8% 20.4% 26.5% 24.9% Capital WIP Financial charges Investment PBT Current Assets Tax Total Assets PAT Extraordinary Items APAT PATM% 13.1% 11.4% 17.4% 16.1% Cash Flow Statement (INR mn) FY08 FY09 FY10 H1FY11 Ratios FY08 FY09 FY10 Debt/Equity (x) Cash Flow from Operating Activities ROCE (%) 59.0% 36.8% 35.6% Cash Flow from Investing Activities Cash EPS (INR) Cash Flow from Financing Activities BV/Share (INR) P/BV at 72(x) Net Cash Flow RoNW (%) 37.8% 23.5% 23.9% Opening Cash EPS (INR) Closing Cash P/E at 72(x) Peer Comparison *Pre Issue Figures Company CMP (INR) M-Cap (INR mn) M-Cap/Sales(x) Sales (INR mn) EPS (INR) P/E (x) BVPS (INR) P/BV (x) Fineotex Chem@ Fineotex Chem@ BSAF Ltd Clariant Chemicals India Pidilite Ind *EPS & BVPS are calculated using post issue shares 4

5 Disclaimer: This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. SPA Securities Limited (hereinafter referred as SPA) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. This document is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The intent of this document is not in recommendary nature. The views expressed are those of analyst and the Company may or may not subscribe to all the views expressed therein The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon such. SPA or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. SPA or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. SPA and/or its affiliates and/or employees may have interests/ positions, financial or otherwise in the securities mentioned in this report. SPA has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement 1. Analyst ownership of the stock - No 2. Group/Directors ownership of the stock No 3. Broking relationship with company covered No This information is subject to change without any prior notice. SPA reserves the right to make modifications and alternations to this statement as may be required from time to time. Nevertheless, SPA is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Research Srinivas Reddy Head of Research srinivas.reddy@spagroupindia.com Tel: Ext. 633 SPA Securities Limited SPA House, Nyay Sagar, Near Gurunanak Hospital, Bandra (E), Mumbai , Tel. No. : For More Information Visit Us At SPA CAPITAL SERVICES LIMITED Investment Advisory services, AMFI Reg. No. ARN-0007 SPA COMTRADE PRIVATE LIMITED Member of NCDEX & MCX. NCDEX TMID , NCDEX FMC no.ncdex/tcm/corp/0714 SPA MERCHANT BANKERS LTD. SEBI registered Category-1 Merchant Bankers SEBI Regn. No. INM SPA INSURANCE BROKING SERVICES LTD. Direct Broker for Life and General Insurance broking IRDA Lic. Code No. DB053/03 SPA Securities Ltd. Membership SEBI Regn. No. NSE CM & WDM INB NSE F&O INF NSE CD&IRF INE BSE CM & WDM INB BSE CD INE MCX-SX CD INE OTCEI Cash INB DP CDSL IN-DP-CDSL-485- DP NSDL IN-DP-NSDL-316- SEBI PMS INP